Phase 2 Study of Sorafenib in Malignant Mesothelioma Previously Treated with Platinum-Containing Chemotherapy-Reference-Cited by-同舟云学术

Phase 2 Study of Sorafenib in Malignant Mesothelioma Previously Treated with Platinum-Containing Chemotherapy

Published:2013-06 Issue:6 Volume:8 Page:783-787
ISSN:1556-0864
Container-title:Journal of Thoracic Oncology
language:en
Short-container-title:Journal of Thoracic Oncology

Author:

Papa Sophie,Popat Sanjay,Shah Riyaz,Prevost A. Toby,Lal Rohit,McLennan Blair,Cane Paul,Lang-Lazdunski Loic,Viney Zaid,Dunn Joel T.,Barrington Sally,Landau David,Spicer James

Publisher

Elsevier BV

Subject

Pulmonary and Respiratory Medicine,Oncology

Reference38 articles.

1. Diffuse pleural mesothelioma and asbestos exposure in the North Western Cape Province;Wagner;Br J Ind Med,1960

2. The expected burden of mesothelioma mortality in Great Britain from 2002 to 2050;Hodgson;Br J Cancer,2005

3. Phase III study of pemetrexed in combination with cisplatin versus cisplatin alone in patients with malignant pleural mesothelioma;Vogelzang;J Clin Oncol,2003

4. Randomized Phase III Study of Cisplatin With or Without Raltitrexed in Patients With Malignant Pleural Mesothelioma: An Intergroup Study of the European Organisation for Research and Treatment of Cancer Lung Cancer Group and the National Cancer Institute of Canada

5. Co-expression of vascular endothelial growth factor and its receptor flt-1 in malignant pleural mesothelioma;König;Respiration,2000

Cited by 74 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Malignant Pleural Mesothelioma;Challenges in Pleural Pathology - Diagnostics, Treatment and Research;2024-07-10

2. Efficacy and safety profile of combining antiangiogenic agents with chemotherapy in patients with advanced malignant pleural mesothelioma: A systematic review and meta-analysis of randomized controlled trials;PLOS ONE;2023-12-21

3. Pleural mesothelioma: a snapshot of emerging drug targets and opportunities for non-surgical therapeutic advancement;Expert Opinion on Therapeutic Targets;2023-11-02

4. Target Therapy in Malignant Pleural Mesothelioma: Hope or Mirage?;International Journal of Molecular Sciences;2023-05-23

5. Genomic and transcriptomic analyses identify a prognostic gene signature and predict response to therapy in pleural and peritoneal mesothelioma;Cell Reports Medicine;2023-02